4D Molecular Therapeutics Inc (FDMT): Gewinn- und Verlustrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 92.008 | 85.209 | 37 | 20.723 | 3.129 | 18.038 | 13.612 | 6.986 | 14.130 | 5.790 |
Herstellungskosten | 53.362 | 7.625 | 141.299 | 97.096 | 3.880 | 3.020 | 53.038 | 38.718 | 18.362 | 13.573 |
Bruttoergebnis | 38.646 | 77.584 | -141.262 | -76.373 | 3.129 | 18.038 | -39.426 | -31.732 | -4.232 | -7.783 |
▸ Brutto-Marge | 42% | 91,05% | -381.789,19% | -368,54% | 100% | 100% | -289,64% | -454,22% | -29,95% | -134,42% |
Betriebliche Aufwendungen | 235.761 | 237.131 | 46.579 | 36.494 | 113.161 | 89.371 | 17.238 | 19.032 | 6.167 | 3.489 |
Operativer Gewinn/Verlust | -197.115 | -159.547 | -187.841 | -112.867 | -110.032 | -71.333 | -56.664 | -50.764 | -10.399 | -11.272 |
▸ Operative Marge | -214,24% | -187,24% | -507.678,38% | -544,65% | -3.516,52% | -395,46% | -416,28% | -726,65% | -73,6% | -194,68% |
Zinsen (Netto) | 18.153 | 19.475 | 27.050 | 9.169 | -3.845 | -2.899 | - | 1.504 | 850 | 89 |
▸ Zinsausgaben | - | - | - | - | 6.418 | 3.036 | 152 | - | - | - |
▸ Zinseinnahmen | 18.153 | 19.475 | 27.050 | 9.169 | 2.573 | 137 | 152 | 1.504 | 850 | 89 |
Andere Ausgaben | 213 | 37 | 77 | -2.861 | -6.383 | -2.915 | 29 | 46 | 2 | 40 |
Gewinn vor Steuern | -179.175 | -140.109 | -160.868 | -100.837 | -107.494 | -71.317 | -56.693 | -49.306 | -9.551 | -11.223 |
Steueraufwand | - | - | - | 5.581,105 | -6.418 | -3.020 | -152 | 3.633 | 848 | -89 |
Minderheitenanteil | - | - | - | -5.581,105 | - | - | 152 | -3.633 | -848 | 89 |
Nettogewinn/-verlust | -179.175 | -140.109 | -160.868 | -100.837 | -101.076 | -68.297 | -56.693 | -49.306 | -9.551 | -11.223 |
▸ Netto-Marge | -194,74% | -164,43% | -434.778,38% | -486,59% | -3.230,3% | -378,63% | -416,49% | -705,78% | -67,59% | -193,83% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.